The overall goals of the Training and Information Transfer Core (TITC) continue unchanged. These are: A) To increase awareness of and impart a body of knowledge about gerontology, neuroscience and AD in particular, and of the care of the DAT patient. B) To encourage more favorable attitudes toward and responsibility within our community for the care of DAT patients. C) To maintain and enhance our collaboration and cooperation with community agencies, resources, and healthcare practitioners who serve DAT patients and their families. D) To promote and improve research in Alzheimer's disease and to facilitate the exchange of knowledge among researchers both within and outside the Washington University community. E) To facilitate the recruitment efforts of the clinical core. We will continue to provide a broad spectrum of educational programs and materials for a diverse community of health care professionals, allied service professionals and community lay persons throughout the Midwest. We propose to expand our current activities by explicitly expanding Specific Aim A in two directions. These additional aims are: A1) To develop and increase educational programs for the African-American community (a currently underserved group) and to promote the advancement of African-American professionals in neuroscience, gerontology and AD- related training. A2) To consolidate and expand our outreach to the young student, further promoting knowledge of and positive attitudes toward the elderly and those suffering from neurological disorders such as AD, and to encourage neuroscience and aging research and care careers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005681-13
Application #
5204525
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Ibanez, Laura; Dube, Umber; Davis, Albert A et al. (2018) Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease. Front Neurosci 12:230
Schindler, Suzanne E; Gray, Julia D; Gordon, Brian A et al. (2018) Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement 14:1460-1469
Roe, Catherine M; Babulal, Ganesh M; Mishra, Shruti et al. (2018) Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. J Alzheimers Dis 61:509-513
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Broce, Iris; Karch, Celeste M; Wen, Natalie et al. (2018) Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med 15:e1002504
Lucey, Brendan P; Hicks, Terry J; McLeland, Jennifer S et al. (2018) Effect of sleep on overnight cerebrospinal fluid amyloid ? kinetics. Ann Neurol 83:197-204
Armstrong, Richard A; McKee, Ann C; Stein, Thor D et al. (2018) Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change. Neurol Sci :
Liao, Fan; Li, Aimin; Xiong, Monica et al. (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest 128:2144-2155

Showing the most recent 10 out of 952 publications